Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Output Shock”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Testing effectiveness (Phase 2)Study completedNCT03431077
What this trial is testing

LJPC-501 in Pediatric Patients With Hypotension

Who this might be right for
Catecholamine-resistant Hypotension (CRH)Distributive ShockHigh Output Shock+1 more
La Jolla Pharmaceutical Company 2
Not applicableApproved For MarketingNCT03245528
What this trial is testing

Expanded Access for LJPC-501

Who this might be right for
Catecholamine Resistant Hypotension (CRH)Distributive ShockHigh Output Shock+2 more
La Jolla Pharmaceutical Company
Testing effectiveness (Phase 2)UnknownNCT03623529
What this trial is testing

LJPC-501 in Paediatric Patients With Hypotension Associated With Distributive or Vasodilatory Shock

Who this might be right for
Catecholamine-resistant Hypotension (CRH)Distributive ShockHigh Output Shock+1 more
La Jolla Pharmaceutical Company 100
Early research (Phase 1)Study completedNCT01393782
What this trial is testing

Intravenous AII for the Treatment of Severe Hypotension in High Output Shock: A Pilot Study

Who this might be right for
Septic Shock
George Washington University 20
Large-scale testing (Phase 3)Study completedNCT02338843
What this trial is testing

LJPC-501 in Patients With Catecholamine-Resistant Hypotension

Who this might be right for
Catecholamine-resistant Hypotension (CRH)Distributive ShockHigh Output Shock+1 more
La Jolla Pharmaceutical Company 344